Breakout Stocks of Week 2
NASDAQ was up last week (week 1) by 3.09% ending at 14,972.76 points after gaining 448.69 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Alpine Immune Sciences Inc NASDAQ:ALPN. This stock has had a buy signal since Nov 03, 2023 when the price was $16.07 and is so far up 27.26% to $20.45. Some other companies are on our watchlist to, among these are Simon Property Group Inc NYSE:SPG Cerevel Therapeutics Holdings, Inc. NASDAQ:CERE Intercontinental Hotels Group NYSE:IHG and Sysco Corporation NYSE:SYY which all got a breakout pattern emerging.
| Date | Company | Price | Week 2 |
|---|---|---|---|
| Alpine Immune Sciences Inc | $20.45 | $19.84 | -2.98% |
| Simon Property Group Inc | $146.62 | $141.62 | -3.41% |
| Cerevel Therapeutics Holdings, Inc. | $42.70 | $42.25 | -1.05% |
| Intercontinental Hotels Group | $92.91 | $95.48 | 2.77% |
| Sysco Corporation | $75.75 | $75.21 | -0.713% |
The Alpine Immune Sciences Inc stock price gained 4.02% on the last trading day (Friday, 12th Jan 2024), rising from $19.66 to $20.45. During the last trading day the stock fluctuated 4.13% from a day low at $19.75 to a day high of $20.57. The price has fallen in 6 of the last 10 days but is still up by 4.55% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 62 thousand more shares were traded than the day before. In total, 861 thousand shares were bought and sold for approximately $17.61 million.
On Apr 15, 2024, it was reported that Cowen & Co. gave ALPN a "Hold" grade with a "downgrade" action.
Alpine Immune Sciences Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Alpine Immune Sciences Inc:
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
The Simon Property Group Inc stock price gained 1.55% on the last trading day (Friday, 12th Jan 2024), rising from $144.38 to $146.62. During the last trading day the stock fluctuated 1.52% from a day low at $144.44 to a day high of $146.63. The price has risen in 6 of the last 10 days and is up by 1.62% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 70 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $238.01 million.
On Mar 25, 2024, it was reported that Stephens gave SPG a "Hold" grade with a "hold" action.
Simon Property Group Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Simon Property Group Inc:
Simon is a real estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual sales.
The Cerevel Therapeutics Holdings, Inc. stock price gained 0.141% on the last trading day (Friday, 12th Jan 2024), rising from $42.64 to $42.70. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 0.82% from a day low at $42.44 to a day high of $42.79. The price has been going up and down for this period, and there has been a 0.61% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $117.90 million.
On Dec 07, 2023, it was reported that Piper Sandler gave CERE a "Neutral" grade with a "downgrade" action.
Cerevel Therapeutics Holdings, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Cerevel Therapeutics Holdings, Inc.:
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as well as in phase 1 trial to treat acute anxiety. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; CVL-936, a selective dopamine D3-preferring antagonist, which is in Phase I clinical trial for the treatment of substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder; and CVL-047, selective PDE4 inhibitor for the treatment of major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and an LRRK2 inhibitor program to address disease progression in Parkinson's. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
The Intercontinental Hotels Group stock price gained 0.672% on the last trading day (Friday, 12th Jan 2024), rising from $92.29 to $92.91. During the last trading day the stock fluctuated 1.52% from a day low at $92.49 to a day high of $93.90. The price has been going up and down for this period, and there has been a 2.07% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 117 thousand more shares were traded than the day before. In total, 215 thousand shares were bought and sold for approximately $20.02 million.
On Apr 26, 2022, it was reported that Deutsche Bank gave IHG a "Buy" grade with a "hold" action.
Intercontinental Hotels Group holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Intercontinental Hotels Group:
InterContinental Hotels Group PLC owns, manages, franchises, and leases hotels in the Americas, Europe, Asia, the Middle East, Africa, and Greater China. The company operates hotels under the Six Senses, Regent, InterContinental Hotels & Resorts, Vignette Collection, Kimpton Hotels & Restaurants, Hotel Indigo, EVEN Hotels, HUALUXE, Holiday Inn, Holiday Inn Express, Holiday Inn Club Vacations, avid, Staybridge Suites, Atwell Suites, Candlewood Suites, voco, and Crowne Plaza. It also provides IHG Rewards loyalty program. As of December 31, 2021, the company operated 5,991 hotels and 880,327 rooms in approximately 100 countries. InterContinental Hotels Group PLC was founded in 1777 and is headquartered in Denham, the United Kingdom.
The Sysco Corporation stock price gained 0.398% on the last trading day (Friday, 12th Jan 2024), rising from $75.45 to $75.75. During the last trading day the stock fluctuated 0.94% from a day low at $75.25 to a day high of $75.96. The price has risen in 7 of the last 10 days and is up by 3.71% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 62 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $190.31 million.
On Mar 19, 2024, it was reported that UBS gave SYY a "Buy" grade with a "hold" action.
Sysco Corporation holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Sysco Corporation:
Sysco Corporation, through its subsidiaries, engages in the marketing and distribution of various food and related products primarily to the foodservice or food-away-from-home industry in the United States, Canada, the United Kingdom, France, and internationally. It operates through U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other segments. The company distributes frozen foods, such as meats, seafood, fully prepared entrées, fruits, vegetables, and desserts; canned and dry foods; fresh meats and seafood; dairy products; beverage products; imported specialties; and fresh produce. It also supplies various non-food items, including paper products comprising disposable napkins, plates, and cups; tableware consisting of China and silverware; cookware, which include pots, pans, and utensils; restaurant and kitchen equipment and supplies; and cleaning supplies. The company serves restaurants, hospitals and nursing homes, schools and colleges, hotels and motels, industrial caterers, and other foodservice venues. As of August 27, 2021, it operated 343 distribution facilities. Sysco Corporation was incorporated in 1969 and is headquartered in Houston, Texas.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
